Bilastine Impurity 12
|
|
Bilastine Impurity 12 Eigenschaften
- Siedepunkt:
- 636.9±65.0 °C(Predicted)
- Dichte
- 1.12±0.1 g/cm3(Predicted)
- pka
- 8.70±0.10(Predicted)
Sicherheit
Bilastine Impurity 12 Chemische Eigenschaften,Einsatz,Produktion Methoden
Bilastine Impurity 12 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Bilastine Impurity 12 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 17)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 |
sale@hdimpurity.com | China | 3681 | 58 |
| Quality Control Solutions Ltd. | 0755-66853366 13670046396 |
orders@qcsrm.com | China | 18190 | 56 |
| Hubei Xinyang Medical Technology Co., Ltd | 15347293736 |
2853117764@yongstandards.com | China | 9999 | 58 |
| Molcoo Chemicals Inc. | 18627923403 |
3001039764@qq.com | China | 8248 | 58 |
| Huaihua Yuanyanda Biotechnology Co., Ltd | 18711085600 |
1652923704@qq.com | China | 4628 | 58 |
| Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 |
2880126944@qq.com | China | 3162 | 58 |
| Shanghai YuZn Pharm. Technology Co.,Ltd. | 15921286451; 15921286451 |
2010681527@qq.com | China | 4918 | 58 |
| Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 |
2208093734@qq.com | China | 8204 | 58 |
| Nantong Hanfang Biotechnology Co. , Ltd. | hanfangpharma@126.com; 18616537568 |
hanfangpharma@126.com | China | 25801 | 58 |
| Jiangxi Yehong Hospital Technology Co., Ltd | 0793-15967982-804 13970348580 |
yehong_pt@yeah.net | China | 774 | 58 |
- Bilastine Impurity 12
- Bilastine Impurity 15
- Bilastine N-Methoxy-N,2-dimethylpropanamide
- Bilastine impurity 27
- Bilastine Propanamide Impurity
- 2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-N-methoxy-N,2-dimethylpropanamide
- Benzeneacetamide, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-N-methoxy-N,α,α-trimethyl-
- Pilastine impurity 7
- 1638785-18-8




